Sectra Signs Enterprise-wide Imaging Solution Contract With US University Health System

Linköping, Sweden and Shelton, CT—September 5, 2017—International medical imaging IT and cybersecurity company Sectra (STO: SECT B) announces that Temple University Health System (TUHS) will install Sectra PACS throughout their multi-hospital system. The Sectra enterprise imaging solution will provide an integrated master patient index with linking capabilities. By joining an unlimited number of patient identifiers, all TUHS healthcare providers will have access to the complete patient record, regardless of its origin.

The multi-year agreement includes Sectra PACS for a full suite of radiology and mammography functionality, a complete advanced visualization portfolio as well as a pre-operative planning solution in 2D and 3D for orthopaedic surgery. The software will support patient care at all imaging locations within the healthcare system.

“TUHS’s focus on advanced medical treatments, cancer care and medical education align very closely with our core values at Sectra. We are looking forward to implementing our enterprise-wide imaging solution at this prestigious healthcare system,” says Mikael Anden, President of Sectra North America.

Sectra Enterprise Image Management
Sectra’s complete enterprise imaging offering is modular and supports the most image-intense departments—radiology, pathology, cardiology and orthopaedics. Being built on the same technical platform, customers can easily extend a departmental solution to create a comprehensive VNA and enterprise image management solution without major investments or the replacement of existing components.

For further information, please contact:

Dr. Torbjörn Kronander
CEO and President Sectra AB
+46(0)705-23-52-27

Marie Ekström Trägårdh
Executive Vice President
Sectra AB and President Sectra Imaging IT Solutions
+46(0)708-23-56-10

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.